Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial

Overview of attention for article published in Frontiers in endocrinology, November 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Readers on

mendeley: 55 Mendeley

Summary Policy documents X

So far, Altmetric has seen 2 policy documents that reference this research output.

What is the effect of population-level screening of asymptomatic adults for type 2 diabetes mellitus or intermediate hyperglycaemia on health outcomes

Cited by World Health Organization on 31 Dec 2024

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Can type 2 diabetes and its associated complications be prevented or delayed in people with intermediate hyperglycaemia?

Cited by World Health Organization on 08 Jul 2024

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.